Show simple item record

dc.contributor.authorBalzarini, Jan
dc.contributor.authorLaethem, Kristel van
dc.contributor.authorPeumans, Willy J.
dc.contributor.authorDamme, Els J. M. van
dc.contributor.authorBolmstedt, Anders
dc.contributor.authorGago Badenas, Federico 
dc.contributor.authorSchols, Dominique
dc.date.accessioned2009-11-25T13:09:25Z
dc.date.available2009-11-25T13:09:25Z
dc.date.issued2006
dc.identifier.bibliographicCitationJOURNAL OF VIROLOGY, Sept. 2006, p. 8411-8421en_US
dc.identifier.urihttp://hdl.handle.net/10017/5045
dc.description.abstractLimited data are available on the genotypic and phenotypic resistance profile of the alpha-(1-2)mannose oligomer-specific prokaryotic lectin cyanovirin (CV-N). Therefore, a more systematic investigation was carried out to obtain a better view of the interaction between CV-N and human immunodeficiency virus type 1 (HIV-1) gp120. When HIV-1-infected CEM cell cultures were exposed to CV-N in a dose-escalating manner, a total of eight different amino acid mutations exclusively located at N-glycosylation sites in the envelope surface gp120 were observed. Six of the eight mutations resulted in the deletion of high-mannose type N-glycans (i.e., at amino acid positions 230, 332, 339, 386, 392, and 448). Two mutations (i.e., at position 136 and 160) deleted a complex type N-glycan in the variable V1/V2 domain of gp120. The level of phenotypic resistance of the mutated virus strains against CV-N generally correlated with the number of glycan deletions in gp120, although deletion of the glycans at N-230, N-392, and N-448 generally afforded a more pronounced CV-N resistance than other N-glycan deletions. However, the extent of the decrease of antiviral activity of CV-N against the mutated virus strains was markedly less pronounced than observed for alpha(1-3)- and alpha(1-6)-mannose-specific plant lectins Hippeastrum hybrid agglutinin (HHA) and Galanthus nivalis agglutinin (GNA), which points to the existence of a higher genetic barrier for CV-N. This is in agreement with a more consistent suppression of a wider variety of HIV-1 clades by CV-N than by HHA and GNA. Whereas the antiviral and in vitro antiproliferative activity of CV-N can be efficiently reversed by mannan, the pronounced mitogenic activity of CV-N on peripheral blood mononuclear cells was unaffected by mannan, indicating that some of the observed side effects of CV-N are unrelated to its carbohydrate specificity/activity.en_US
dc.format.mimetypeapplication/pdfen
dc.language.isoengen_US
dc.publisherAmerican Society for Microbiologyen_US
dc.titleMutational Pathways, Resistance Profile, and Side Effects of Cyanovirin Relative to Human Immunodeficiency Virus Type 1 Strains with N-Glycan Deletions in Their gp120 Envelopesen_US
dc.typeinfo:eu-repo/semantics/articleen
dc.subject.ecienciaCienciaes_ES
dc.subject.ecienciaFarmacologíaes_ES
dc.subject.ecienciaScienceen
dc.subject.ecienciaPharmacologyen
dc.contributor.affiliationUniversidad de Alcalá. Departamento de Farmacología
dc.relation.publisherversionhttp://dx.doi.org/10.1128/JVI.00369-06
dc.type.versioninfo:eu-repo/semantics/publishedVersionen_US
dc.identifier.doi10.1128/JVI.00369-06
dc.rights.accessRightsinfo:eu-repo/semantics/openAccessen


Files in this item

Thumbnail

This item appears in the following Collection(s)